According to RVL Pharmaceuticals's latest financial reports the company has S$26.28 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | S$59.71 M | 1.52% |
2021-12-31 | S$58.81 M | -61.02% |
2020-12-31 | S$0.15 B | 16.75% |
2019-12-31 | S$0.12 B | 33.56% |
2018-12-31 | S$96.77 M | 108.25% |
2017-12-31 | S$46.46 M | 64.16% |
2016-12-31 | S$28.3 M |